$CERC FDA Accepts IND Application for Investigational Drug CERC801 for the treatment of PGM1 Deficiency httpsglobenewswire.comnewsrelease2019012217032190enFDAAcceptsINDApplicationforCerecorsInvestigationalDrugCERC801forthetreatme

$CERC FDA Accepts IND Application for Investigational Drug CERC-801 for the treatment of PGM1 Deficiency https://globenewswire.com/news-release/2019/01/22/1703219/0/en/FDA-Accepts-IND-Application-for-Cerecor-s-Investigational-Drug-CERC-801-for-the-treatme

06:32 EST 22 Jan 2019 | Odi Bruckman

$CERC FDA Accepts IND Application for Investigational Drug CERC-801 for the treatment of PGM1 Deficiency https://globenewswire.com/news-release/2019/01/22/1703219/0/en/FDA-Accepts-IND-Application-for-Cerecor-s-Investigational-Drug-CERC-801-for-the-treatment-of-PGM1-Deficiency.html …

More From BioPortfolio on "$CERC FDA Accepts IND Application for Investigational Drug CERC-801 for the treatment of PGM1 Deficiency https://globenewswire.com/news-release/2019/01/22/1703219/0/en/FDA-Accepts-IND-Application-for-Cerecor-s-Investigational-Drug-CERC-801-for-the-treatme"